Carolina Clinical Research specializes in pulmonary (lung) disorders. With several trials available, we are on the front lines of developing new treatments for many pulmonary disorders, including COPD.
We currently are conducting two clinical trials, RPL554-CO-302: A Phase 3 Trial to Evaluate the Safety and Efficacy of Ensifentrine in Patients with COPD, and EFC16750: Study to Assess the Efficacy, Safety, and Tolerability of SAR440340?REGN3500/Itepekimab in Chronic Obstructive Pulmonary Disease (COPD) (AERIFY-1).
Carolina Clinical Research conducts clinical trials in several areas. Working closely with drug manufactures and study sponsors, we ensure the safe, comfortable, and effective administration of clinical trial medications.
While we may have trials covering several clinical areas, our principal investigators and clinical staff specialize in the following study areas: